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In biological systems, pathways define complex interaction networks where multiple molecular elements are involved in a series
of controlled reactions producing responses to specific biomolecular signals. These biosystems are dynamic and there is a need for
mathematical and computational methods able to analyze the symbolic elements and the interactions between them and produce
adequate readouts of such systems. In this work, we use rewriting logic to analyze the cellular signaling of epidermal growth factor
(EGF) and its cell surface receptor (EGFR) in order to induce cellular proliferation. Signaling is initiated by binding the ligand
protein EGF to the membrane-bound receptor EGFR so as to trigger a reactions path which have several linked elements through
the cell from the membrane till the nucleus. We present two different types of search for analyzing the EGF/proliferation system
with the help of Pathway Logic tool, which provides a knowledge-based development environment to carry out the modeling of the
signaling. The first one is a standard (forward) search. The second one is a novel approach based on narrowing, which allows us to
trace backwards the causes of a given final state. The analysis allows the identification of critical elements that have to be activated
to provoke proliferation.
1. Symbolic Systems Biology
The technological advances in the analysis of global gene
expression and the growth of genomic sequence information
have revolutionized research in biology and biomedicine
[1, 2]. Investigation of mammalian signaling processes, the
molecular pathways by which cells detect, convert, and
internally transmit information from their environment to
intracellular targets such as the genome, would greatly benefit
from the availability of predictive models [3–5].
The goal of our research is to develop abstract qualitative
models of metabolic and signaling processes that can be
used as the basis of further analyses by powerful tools
(e.g., formal verification and model checking with formal
methods). We model and analyze the biological processes by
which an initial cellular system can lead to the activation of
proliferation signaling by using a ligand/receptor pathway.
The cells receive external signals by certain biomolecules
(ligands) that are able to interact with certain receptors on
the cellular surface producing some effects inside the cell [6].
A ligand/receptor system consists of a pathway with multiple
elements and known reactions that have been modeled using
Maude language by Pathway Logic in a natural, efficient way.
In this work, we use a knowledge base provided by
the Pathway Logic system [7]. EGF signaling pathway was
selected taking into account its relevance in carcinogenic pro-
cesses. A novel backward search system has been developed
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in accordance with the theoretical foundations provided by
narrowing. Moreover, we present an application of classical
forward search with EGF signaling pathway. Authors have
published other forward search applications in [8–10].
Various approaches for computational analysis of cellular
signaling networks have been proposed to simulate responses
to specific stimuli [11, 12]. Simulations using in silico models
founded on kinetic measurements of signaling pathways
or networks allow us to achieve a detailed understanding
of the biochemistry of signal transduction [13]. Ordinary
differential equations or stochastic approaches are some of
the quantitative methods. The use of differential equations to
fit changes in the concentrations from the input to the output
is an adequate approach when for a given pathway there
are a large amount of quantitative information and a small
number of reactions to be modeled [14, 15]. In many cases,
however, qualitative approaches (e.g., logic modeling) are
more convenient to model complex cell signaling pathways.
Symbolic models are based on formalisms that provide
a language to represent the states of a system, mechanisms to
model their changes (such as reactions), and tools for analysis
based on computational or logical inference. A variety of
formalisms have been used to develop symbolic models of
biological systems, including Petri nets [16, 17], statecharts
[18], live sequence charts [19], ambient/membrane calculi
[20], and rule-based systems [21, 22].
In our domain of application, biological interactions
can intuitively be specified by rule-based modeling without
taking account of the underlying complexity. Rule-based
approaches prevent the combinatorial explosion that results
from molecular entities existing under multiple conditions.
Kappa [23] and BioNetGen [24] are partly similar to Pathway
Logic from the rule-based modeling formalisms.
In this paper, Section 1 gives an overview of symbolic
systems biology with a rewriting logic and Pathway Logic
approach. In Sections 2 and 3, we analyze the role of
epidermal growth factor signaling in cancer cell proliferation
using narrowing-rewriting techniques. A novel contribution
for backward searches in signaling pathways is described.
Conclusions are drawn in Section 4.
1.1. Cellular Signaling Networks with Pathway Logic Models.
Pathway Logic (PL) provides a symbolic systems biology
approach tomodeling biological processes based on rewriting
logic [7, 25, 26]. PL makes it possible to build and analyze
models with multiple levels of detail, give information and
representations of general rules, define novel data sorts and
their properties, and use logical inference for executing
queries.
PL primarily allows us to develop abstract qualitative
models of signaling and metabolic processes. These models
can be used as the basis for analysis by powerful tools to
query dynamics on complex biological pathways. A number
of recent contributions show their potential for inferring
executable models [28] and analyzing the dynamics in dif-
ferent signaling transduction pathways (e.g., nerve growth
factor, hepatocyte growth factor, or interleukin-6 signaling
pathways) [8–10]. PL also enables developing quantitative and
probabilistic models [29].
1.2. Rewriting Logic and Maude. Rewriting logic [30, 31] is
logic of change that has been successfully applied to represent
many different kinds of concurrent systems. A theory in
rewriting logic consists of an equational theory, which allows
the user to specify sorts, constructors and function symbols
(possibly including some equational axioms), and equality
between terms. Rewriting logic extends this equational the-
ory by adding the notion of rewrite rule, which represents
transitions between states.
A simple example of rewriting logic theory specification
would be a vending machine that we assume to be composed
of a multiset of products (e.g., apples and chocolate) and
money (only quarters and dollars are allowed). The sort
(i.e., the datatype) required for this theory would be the
multiset, whose constructors would be the empty multiset,
an apple, a chocolate, a quarter, a dollar, and the union of
smaller multisets. Note that the union is commutative (it
is unimportant whether we have a quarter and a dollar or
a dollar and a quarter) and associative (it is unimportant
whether we put together a chocolate with the multiset
composed of a quarter and a dollar or we put together the
multiset composed of a chocolate and a quarter with a dollar)
and has the empty multiset as identity (a multiset does not
change by adding the empty multiset). Possible rewrite rules
would be the one that transforms a dollar into four quarters,
the one that transforms a dollar into a chocolate and one
quarter, or the one that transforms two quarters into an apple.
Using the idea of transition between states, it is possible to
model biological systems in rewriting logic in a very natural
way: while cells are just a set of multisets standing for the
different components appearing in a real cell, biochemical
reactions are represented by means of rules.
Rewriting logic is efficiently implemented in Maude [32,
33]. In the case of Maude, the underlying equational theory
is Membership Equational Logic [34], which in addition to
equations allows the user to define membership axioms stat-
ing the members of a sort. Maude provides several analysis
tools for rewrite theories, including a rewrite computation,
breadth-first search, and LTL model checking. Using these
features, it is possible to study how our system behaves, to
check whether it is possible to reach a certain state from
an initial one, and to analyze whether our system verifies
some temporal properties. Moreover, since rewriting logic
is reflexive [35], a key distinguishing feature of Maude is its
metalevel, which allows users to manipulate Maude modules
and terms as standard data [36].
2. Case Study: EGF Signaling Pathway
We present in this section the case study that will be used to
illustrate our technique in Section 3. It is interesting to discuss
here the contributions made by these sections: Section 2
describes the pathway of interest and explains how to perform
forward analysis, which requires a similar approach to the
ones followed by the authors and others when analyzing
other pathways. On the other hand, the backward analysis in
Section 3 is completely novel; to the best of our knowledge
it has never been used in a system following a transitional
scheme. Even though the foundations of the analysis are the
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Figure 1: Human EGF signaling pathway (reprinted from Biocarta [27]).
rules described in Section 2, they are automatically trans-
formed in order to apply the backward search, which in turn
is not implemented in the core distribution of Maude and
hence requires further modifications to be used. Moreover,
this analysis is completely general and can be applied to any
other pathway without further modifications.
2.1. Epidermal Growth Factor Signaling Pathway. The ErbB
family of the receptor tyrosine kinases contains the epidermal
growth factor receptor (EGFR) [38, 39]. These receptors
couple the binding of the extracellular growth factor lig-
ands to intracellular signaling pathways that control various
biologic responses such as proliferation, differentiation, cell
motility, and survival [40–45].Threemajor steps are involved
in the activation of EGFR-dependent intracellular signaling
[46]: (a) the binding of a receptor-specific ligand takes place
in the extracellular portion of the EGFR or of one of the
EGFR-related receptors; (b) the formation of a functionally
active EGFR-EGFR dimer or a heterodimer causes the ATP-
dependent phosphorylation of specific tyrosine residues in
the EGFR intracellular domain; and (c) this phosphorylation
triggers a complex program of intracellular signals to the
cytoplasm and then to the nucleus.
EGFR activates two major intracellular pathways: (i)
the RAS-RAF-MEK-MAPK pathway, which controls gene
transcription, cell-cycle progression from the G1 phase to
the S phase, and cell proliferation, and (ii) the PI3K-Akt
pathway, which activates a cascade of antiapoptotic and
prosurvival signals: bFGF, basic fibroblast growth factor, HB-
EGF, heparin-binding EGF, MAPK, mitogen-activated pro-
tein kinase, PI3K, phosphatidylinositol 3,4,5-kinase, TGFa,
transforming growth factor alpha, and VEGF, vascular
endothelial growth factor (Figure 1).
The binding between EGFR and ligand triggers down-
stream intracellular signaling pathways. Some of them
include the PI3K-AKT prosurvival, STAT transcription, and
RAS-RAF-MEK proliferation pathways [47]. The RAS-RAF-
MEK and PI3K-AKT pathways are mostly activated by the
anaplastic lymphoma kinase (ALK) fusion proteins. Cell
proliferation, cell motility, and carcinogenesis are driven by
the amplification of the EGFR and ALK signaling pathways
(Figure 2).
2.2. Modeling: Dishes and Rewrite Rules. Some dishes and
rules of the STM7 Pathway Logic knowledge base are defined
below. A formal knowledge base contains information about
the changes that occur in the proteins inside a cell in response
to exposure to receptor ligands, chemicals, or various stresses.
In our case study, we will focus on models of response to







Figure 2: The binding between EGFR and ligand gives rise to intracellular signaling pathways including the RAS/RAF/MEK proliferation
pathways [37].
epidermal growth factor (EGF) stimulation. Somatic muta-
tions that lead to EGFR overactivity or upregulation are
associated with several types of cancer (e.g., glioblastoma
multiforme (GBM), lung cancer, or anal cancers). These
mutations involving EGFR lead to its constant activation,
which produces uncontrolled cell division. EGFR signal
transduction pathways include reactions and, in fact, can
induce cellular proliferation activating proteins ERK inside
the cells.
An initial state or dish (called EgfDish) with several
locations and elements is defined:
(i) The outside (location tag XOut) contains the epider-
mal growth factor (Egf).
(ii) The EgfRC location contains the epidermal growth
factor receptor (EgfR).
(iii) The CLo location, which contains the elements stuck
to the outside of the plasma membrane, is empty.
(iv) The membrane (location tag CLm) contains proteins
Erbb2, Pag1, and Plscr1.
(v) The inside of the membrane (location tag CLi) con-
tains several proteins binding to guanosine diphos-
phate GDP, Cdc42, Hras, Kras, and so forth, and
some other proteins, Gnai1, Gnai3, Pld1, and so
forth (see the full code shown in Box 1).
(vi) The cytoplasm (location tag CLc) contains enzyme
Pi3k and some proteins, Abl1, Akt1, Araf,
ArhGap5, and so forth.
(vii) The nucleus (location tag NUc) contains several pro-
teins (Atf1, Creb1, Elk1, etc.).
In Maude syntax, this dish (called EgfDish) is expressed by
the equation shown in Box 1.
Rewrite rules detail the behavior of cell components
depending on biological contexts and modification states.
Each rule represents an action in a biological process such as
intra/intercellular signaling reactions or metabolic reactions.
2.2.1. Rewrite Rule 001.EgfR.irt.Egf. Pathway Logic con-
tains a set of transition rules, derived from curated experi-
mental findings.They provide an explanation of how a signal
propagates in response to an EGF stimulus. Here, we describe
rule 001, directly sourced from the literature. Yarden and
Sliwkowski [48] determine that when EGF and its relatives
bind the ErbB family of receptors, they trigger a network of
signaling pathways, culminating in responses ranging from
cell division to death and from motility to adhesion.
Our rewrite rule 001 establishes the following: in the
presence of epidermal growth factor Egf in the outside of the
cell (XOut), the receptor EgfR is phosphorylated on tyrosine
([EgfR - Yphos]) and binds to protein EGF (Egf) [48, 49].
In Maude syntax, this signaling process is expressed by the
rewrite rule shown in Box 2.
2.2.2. Rewrite Rule 188.Shp2.irt.Egf. When protein EGF
(Egf) is bound to its receptor EGFR phosphorylated on tyrosine
([EgfR - Yphos]) and the cytoplasm contains the tyrosine
phosphatase Shp2, thenShp2 is phosphorylated on tyrosine and
recruited to the EgfRC container [50]. This signaling process
is expressed by the Maude rewrite rule shown in Box 3.
2.2.3. Rewrite Rule 529.Hras.irt.Egf. When protein EGF
(Egf) is bound to its receptor EGFR phosphorylated on tyro-
sine ([EgfR - Yphos]), the GRB2-associated-binding pro-
tein Gab1 or Gab2 phosphorylated on tyrosine is present
([gab:GabS - Yphos]), the Ras guanyl-releasing protein 3
RasGrp3 or protein Sos1 phosphorylated on tyrosine is
present, Pi3k is present, the protein Shp2 phosphorylated on
tyrosine is present, and the inside of the membrane (Cli)
contains Hras loaded with guanosine diphosphate GDP, then
Hras switches its load to guanosine 5󸀠-triphosphate GTP [51].
The rewrite rule shown in Box 4 represents this signaling
process.
Figure 3 shows the aforementioned rules using the
Pathway Logic Assistant. An oval represents a component
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eq EgfDish =
PD ({XOut | Egf} {EgfRC | EgfR} {CLo | empty} {CLm | Erbb2 Pag1 Plscr1}
{CLi | [Cdc42 - GDP] [Hras - GDP] [Kras - GDP] [Nras - GDP]
[Rac1 - GDP] [Rala - GDP] [Ralb - GDP] [Rap1a - GDP]
[Rap2b - GDP] [Rit1 - GDP] Gnai1 Gnai3 Pld1 Pld2 Src}
{CLc | (Mlst8 : Mtor : Raptor) [Gsk3s - act] Abl1 Akt1 Araf ArhGap5
ArhGef4 ArhGef7 Atf2 Bmx Braf Cbl Cblb Cin85 Crk CrkL Csk Dbl
Dok1 Dok2 Eif4ebp1 EndA1 Eps8 Eps15 Erk5 Erks Fak1 Fak2 Flna
Freud1 Gab1 Gab2 Git1 Grb2 Hpk1 Ipo7 IqGap1 Jak1 Jak2 Jnks Lkb1
Mapkapk2 Mek1 Mek5 Mekk1 Mekk2 Mekk3 Mlk3 Nckipsd P38s Pdpk1
Pi3k Pkcd Pkcz Plcg1 Plce1 Ptk6 Pxn Raf1 RalGds RapGef1 Rasa1
RasGrp3 Rela Rictor Rin1 Rps6 Rsk1 Rsk2 Rsk3 S6k1 Sh2d3a Sh2d3c
Shc1 Shoc2 Shp2 Sin1 Smad3 Sos1 Stat1 Stat3 Stat5a Stat5b Tnk2
Tns3 Ube2l3 Vav1 Vav2 Vav3 Ywhaz Y196 Y1122}
{NUc | Atf1 Creb1 Elk1 Fos HistH3 Jun Msk1 Msk2 Myc} ) .
Box 1
rl [001.EgfR.irt.Egf]:
{XOut | xout Egf} {EgfRC | egfrc EgfR}
=> {XOut | xout} {EgfRC | egfrc ([EgfR - Yphos] : Egf)} .
Box 2
rl [188.Shp2.irt.Egf]:
{EgfRC | egfrc ([EgfR - Yphos] : Egf )} {CLc | clc Shp2}
=> {EgfRC | egfrc ([EgfR - Yphos] : Egf ) [Shp2 - Yphos]} {CLc | clc} .
Box 3
(e.g., gene, protein) participating in a reaction. A rectangle
illustrates a reaction rule with a label which represents
its shortened identifier in the knowledge base. A solid
arrow from an occurrence oval to a rule indicates that the
occurrence is a reactant. A dashed arrow indicates that the
occurrence is a modifier, enzyme, or control. That is, it is a
necessary element for the reaction to take place but is kept
unchanged by the reaction. A solid arrow from a rule to an
occurrence oval indicates that the occurrence is a product.
2.3. Dynamics: Logical Inferences. Our analysis starts with
the initial dish state EgfDish defined in Section 2.2 and
derived from the knowledge base provided by Pathway Logic.
It is a well-known fact that cell proliferation is connected to
activation of Erks [52]. We want to find out whether there
is a pathway from EgfDish leading to activation of Erks. In
this case, one can use the search command with a suitable
search pattern and parameters ([n]: the first 𝑛 solutions;
=>+: at least one step). The target state is defined by the
operator PD, whose argument is a “soup” of locations with
their respective contents. A soup is amultiset that can include
several elements regardless of their order.
The contents of each location (e.g., EgfRC) are elements
and/or variables (e.g., thEgfRC:Things) according to the
matching criteria of our search. In the nucleus, a protein
prot:BProteinmust be activated and can also have a set of
other modifiers mod:ModSet. The search condition imposes
that the variable prot:BProteinhasmembership in the sort
ErkS (see Box 5).
The solution to this query given by Maude shows
the matching in the previous search pattern. While the
terms fixed by the search pattern are not shown (e.g.,
[EgfR - Yphos]: Egf), the variables are presented with
their corresponding values. The first solution has the values
shown in Box 6.
In this solution, we observe that the variable on-the-
fly prot:BProtein matches protein Erks with modifica-
tions phos (TEY) and phos (SPS). We find out proteins
Braf, Gsk3s, Mlk3, and Mek1 in an activated form in the
cytoplasm. We show evidence of a ligand/receptor effect:
epidermal growth factor (EGF) binds a specific cell surface
receptor (EGFR). Then, we ask Maude for the rule labels
which have been applied to reach the final state according
to the solution < (see Box 7). Some of these rules are
the rewrite rules 001.EgfR.irt.Egf, 188.Shp2.irt.Egf,
and 529.Hras.irt.Egf described in Boxes 2, 3, and 4.
This way, Maude allows us to explore the complete search
space following a breadth-first strategy until all solutions are
found.
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rl [529.Hras.irt.Egf]:
{EgfRC | egfrc ([EgfR - Yphos] : Egf) [gab:GabS - Yphos]
[hrasgef:HrasGEF - Yphos] Pi3k [Shp2 - Yphos]}
{CLi | cli [Hras - GDP]}
=> {EgfRC | egfrc ([EgfR - Yphos] : Egf) [gab:GabS - Yphos]
[hrasgef:HrasGEF - Yphos] Pi3k [Shp2 - Yphos]}





















Figure 3: (a) Rule [001.EgfR.irt.Egf] using Pathway Logic Assistant. (b) Rule [188.Shp2.irt.Egf] using PLA. (c) Rule
[529.Hras.irt.Egf] using PLA.
3. Searching for Causes
In the previous section, we used a standard (forward) search
to analyze the set of reachable states from an initial dish;
now, we can use narrowing to analyze the possible initial
states leading to a particular state. That is, in this section, we
propose a backward search for analyzing the causes leading
to different scenarios. We will first introduce the theoretical
notions underlying our scheme, and then we will show how
the search works.
Narrowing [53–55] is a generalization of the term rewrit-
ing, allowing free variables in terms and replacing pattern
matching by unification in order to reduce these terms. It was
first used to solve equational unification problems [56] and
then generalized to deal with symbolic reachability problems
[57]. More formally, the difference between a rewriting step
and a narrowing step is that in both cases we use a rewrite rule
𝑙 ⇒ 𝑟 to rewrite 𝑡 at a position 𝑝 (we express this subterm as
𝑡|𝑝), but narrowing unifies the left-hand side 𝑙 and 𝑡|𝑝; that is,
it uses a substitution 𝜎 such that 𝑙𝜎 = 𝐴𝑡|𝑝𝜎 before actually
performing the rewriting step, while in rewriting 𝑡|𝑝 must
be an instance of 𝑙 (i.e., only matching is required). From
an initial term 𝑡 only containing variables (except for the
function symbol at the top), we can obtain a substitution 𝜎,
using this narrowing approach, and generate a term 𝑡𝜎, such
that 𝑡𝜎 can be rewritten using the traversed rules to some term
𝑡󸀠. The current implementation of narrowing in Maude has
been applied to symbolic model checking [58] and test-case
generation [59], among others.
Recalling our example for the vending machine from
the previous section, it is easy to see the difference between
standard rewriting and narrowing. Remember that we have a
rule in our system that turns two quarters into an apple; in this
system,wemightwonderwhether it is possible to reach a state
including an apple starting from a system with two quarters.
Using rewriting, we reach a positive answer, as well as starting
from a state with three quarters, from a state with one dollar
(since we can use the rule to transform it into four quarters),
and, in general, from any initial state containing two or more
quarters. However, all these initial states must be concrete
and contain either quarters, dollars, apples, or chocolates.
Applying rewrite to an initial state containing a quarter and
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search [1] in QQ : EgfDish =>+ PD( locOther:Locations
{EgfRC | thEgfRC:Things [EgfR - Yphos] : Egf}
{XOut | thXOut:Things} {CLm | thCLm:Things}
{CLi | thCLi:Things} {CLc | thCLc:Things}
{NUc | thNUc:Things [prot:BProtein - mod:ModSet act]})
such that (prot:BProtein :: ErkS) = true .
Box 5
Solution 1 (state 17589)
locOther:Locations --> {CLo | empty}
thCLm:Things --> Erbb2 Pag1 Plscr1
thCLi:Things --> Gnai1 Gnai3 Pld1 [Cdc42 - GDP] [Hras - GTP] [Kras - GDP]
[Nras - GDP] [Rac1 - GTP] [Rala - GDP] [Rit1 - GDP] Pld2
thXOut:Things --> empty
thCLc:Things --> Abl1 Akt1 Araf Cbl Cblb Crk CrkL Csk Dbl Erk5 Fak1 Gab1
Hpk1 IqGap1 Jak1 Jak2 Jnks Lkb1 Mek5 Mekk1 Mekk2 Mekk3 Nckipsd P38s
Pdpk1 Pkcd Raf1 RapGef1 Rsk1 (Mlst8 : Mtor : Raptor) [Gsk3s - act]
[Braf - act] [Mlk3 - act] [Mek1 - act] Shoc2 Sin1 Smad3 Stat1 Stat3
thNUc:Things --> Atf1 Creb1 Elk1 Fos HistH3 Ipo7 Jun Msk1 Msk2 Myc
prot:BProtein --> Erks
mod:ModSet --> phos (TEY) phos (SPS)
thEgfRC:Things --> Grb2 Pi3k [Fak2 - act] [Gab2 - Yphos] [Git1 - Yphos]
[Pxn - Yphos] [Shp2 - Yphos] [Ptk6 - act] [Shc1 - Yphos]
[Sos1 - Yphos] [Src - act]
Box 6
Maude> show path labels 17589 .
001.EgfR.irt.Egf 117.Grb2.irt.Egf 197.Sos1.irt.Egf 532.Ptk6.irt.Egf
683.Rac1.irt.Egf 188.Shp2.irt.Egf 075.Gab2.irt.Egf 207.Src.irt.Egf
669.Fak2.irt.Egf 398.Git1.irt.Egf 191.Shc1.irt.Egf 172.Pi3k.irt.Egf




a variable standing for a multiset would return a negative
answer, because rewriting is not able to assign values to the
variable (e.g., a quarter in our case) and hence cannot apply
rules. Narrowing, on the other hand, is able to assign values
to variables in order to apply rules, so a narrowing search
would return a positive result and the required substitution
(our variable would be just an apple in 0 steps, a quarter in 1
step, a dollar in 2 steps, etc.).
We can use the rule 01.EgfR.irt.Egf from Sec-
tion 2 to illustrate the difference between rewriting and
narrowing. First, for applying rewriting, we can only
start from ground terms (terms without variables), so we
could start with the term {XOut | Egf} {EgfRC | EgfR}
and obtain the following result by applying the rule
{XOut | none} {EgfRC | [EgfR - Yphos]: Egf}.
Note that starting with a ground term greatly limits
the power of the search, since (i) a slight variation in this
term might imply huge differences in the reachable terms
and (ii) it limits the causes of the reachable states to that
dish, hence ignoring other simpler or more general causes.
In order to solve this problem, narrowing is applied to
terms with variables that stand for potentially infinite
sets of ground terms. In that case, we could start the
process with the term {XOut | xout} {EgfRC | egfrc}.
This way, we do not impose any constraint to the initial
term. The narrowing process would find that the variable
xout must be of the form xout' Egf, while egfrc must
be of the form egfrc' EgfR, for xout' and egfrc'
fresh variables. This way, we would obtain the term
{XOut | xout'} {EgfRC | egfrc' ([EgfR - Yphos]: Egf)},
which is more general than the one above. Since the
narrowing process returns the bindings applied to the initial
variables, we can use it to check whether a state is reachable
from a general term and then obtain the most general initial
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Maude> (search [2] in RULES : PD(L:Locations) ∼>*
PD ({CLo | empty}
{EgfRC | Grb2 Pi3k [Fak2 - act] [Gab2 - Yphos] [Git1 - Yphos]
[Ptk6 - act] [Pxn - Yphos] [Shc1 - Yphos] [Shp2 - Yphos]
[Sos1 - Yphos] [Src - act] [EgfR - Yphos] : Egf}
{XOut | empty}
{CLm | Erbb2 Pag1 Plscr1}
{CLi | Gnai1 Gnai3 Pld1 Pld2 [Cdc42 - GDP] [Hras - GTP] [Kras - GDP]
[Nras - GDP] [Rac1 - GTP] [Rala - GDP] [Rit1 - GDP]}
{CLc | Abl1 Akt1 Araf Cbl Cblb Crk CrkL Csk Dbl Erk5 Fak1 Gab1 Hpk1
IqGap1 Jak1 Jak2 Jnks Lkb1 Mek5 Mekk1 Mekk2 Mekk3 Nckipsd P38s
Pdpk1 Pkcd Raf1 RapGef1 Rsk1 Shoc2 Sin1 Smad3 Stat1 Stat3
(Mlst8 : Mtor : Raptor) [Braf - act] [Gsk3s - act] [Mlk3 - act]
[Mek1 - act]}
{NUc | Atf1 Creb1 Elk1 Fos HistH3 Ipo7 Jun Msk1 Msk2 Myc




{CLc | Abl1 Akt1 Araf Cbl Cblb Crk CrkL Csk Dbl Erk5 Fak1 Gab1 Gab2 Hpk1
IqGap1 Jak1 Jak2 Jnks Lkb1 Mek5 Mekk1 Mekk2 Mekk3 Nckipsd P38s Pdpk1
Pkcd Raf1 RapGef1 Rsk1 Shoc2 Sin1 Smad3 Stat1 Stat3 [Mlk3 - act]
(Mlst8 : Mtor : Raptor)[Braf - act][Gsk3s - act][Mek1 - act]}
{CLi | Gnai1 Gnai3 Pld1 Pld2[Cdc42 - GDP][Hras - GTP][Kras - GDP]
[Nras - GDP][Rac1 - GTP][Rala - GDP][Rit1 - GDP]}
{CLm | Erbb2 Pag1 Plscr1}
{CLo | empty}
{EgfRC | Grb2 Pi3k(Egf :[EgfR - Yphos]) [Fak2 - act] [Git1 - Yphos]
[Ptk6 - act][Pxn - Yphos][Shc1 - Yphos][Shp2 - Yphos][Sos1 - Yphos]
[Src - act]}
{NUc | Atf1 Creb1 Elk1 Fos HistH3 Ipo7 Jun Msk1 Msk2 Myc
[Erks - act phos (SPS) phos (TEY)]}
{XOut | empty}
Box 9
term required to reach this state, hence allowing us to discard
the infinite initial dishes that are a particularization of this
solution.
However, due to its computational power, narrowing
poses a number of important restrictions. First, it can only be
applied to unconditional theories. Secondly, since unification
is only available for some particular theories, only some
combinations of equational axioms are allowed. Finally, it is
required for all the rewrite rules to be defined at the top (the
rules must be applied to the complete term and not just to the
subterms). Luckily enough, the Pathway Logic specification
fulfills the first two constraints, although it fails to fulfill
the last one. For this reason, we have developed a way to
apply narrowing to any pathway. It is worth discussing the
entity and complexity of this extension, whose main points
are as follows: (i) it is a metalevel function, which is able
to modify the rules in a given module to make them fulfill
the constraints above, and (ii) it is Full Maude [32], since
narrowing is not implemented in the built-in distribution of
Maude but in its Full Maude extension. The former poses
theoretical difficulties, since it requires a deep understanding
of the structure of Maude modules, terms, and sorts at the
metalevel, while the latter poses technical difficulties, since it
requires the programmer to deal with the input/outputmech-
anisms and the explicit database used by Full Maude. This
extension is available at https://github.com/ariesco/pathway.
For example, we look for the different dishes that can
produce the first result for the search in Section 2.3 by using
Box 8.
Although the first solution just indicates that we can reach
this result by applying no rewrite rules and starting with the
same substitutionwe are looking for, the second solution goes
one step backwards and proposes the initial state shown in
Box 9.
By looking for further solutions, Maude keeps going
backwards until the initial dish is as general as needed by the
user. Also note that the initial dish can be further specialized
to indicate that we expect some initial components or to
BioMed Research International 9
focus in a particular element.We consider that this technique,
which has been proposed for the first time in this paper, will
be very useful for analyzing the causes of many pathways.
4. Conclusions
In the last few years, the analysis of biological systems
has required an overwhelming and boundless amount of
quantitative data with the use of new technologies [60–63].
Obtaining quantitative data in vivo and/or in vitro is often
complicated due to ethical aspects or certain limits concern-
ing experimentation. Quantitativemethods formodeling and
analysis of biochemical networks are infeasible inmany cases.
The dynamics of complex biological systems can be
explained by developing symbolic methods [64]. Molecular
biologists can formalize models to think about signaling
pathways and their behavior, allowing them to computation-
ally raise questions about their dynamics and outcomes.
Rewriting logic provides a logical framework that gives us
the ability to build and analyze models with multiple levels of
detail [32]. Different sorts of elements (proteins, genes, cell
locations, etc.) and their properties can be defined. Biological
rules can be easily represented. Maude language allows us to
perform searches using logical inference.
In this paper, we have described two different searches
for studying the epidermal growth factor in the Maude
implementation of the Pathway Logic. The first one allows
the user to study how different particular dishes can evolve
by applying a breadth-first search by rewriting, hence being
able to check whether a certain state is reachable. The second
search presents a novel approach by applying narrowing
instead of rewriting, which allows the user to trace back
the possible origins of a given scenario, hence providing
a causality study. In order to perform this analysis, we
have extended Full Maude, the tool where the narrowing
capabilities ofMaude are implemented, with a command that
preprocesses the Pathway Logicmodules in order to fulfill the
narrowing requirements. We expect that this novel approach
will be useful for analyzing other pathways where the forward
approach has already been used.
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[9] G. Santos-Garćıa, C. L. Talcott, A. Riesco, B. Santos-Buitrago,
and J. De Las Rivas, “Role of nerve growth factor signaling
in cancer cell proliferation and survival using a reachability
analysis approach,” in Proceedings of the 10th International
Conference on Practical Applications of Computational Biology
& Bioinformatics (PACBB ’16), M. S. Mohamad, M. P. Rocha,
F. Fdez-Riverola, F. J. D. Mayo, and J. F. D. Paz, Eds., vol. 477
of Advances in Intelligent Systems and Computing, pp. 173–181,
Springer, Sevilla, Spain, June 2016.
[10] G. Santos-Garćıa, C. L. Talcott, and J. De Las Rivas, “Analysis
of cellular proliferation and survival signaling by using two
ligand/receptor systems modeled by Pathway Logic,” in Hybrid
Systems Biology: Fourth International Workshop, HSB 2015,
Madrid, Spain, September 4-5, 2015. Revised Selected Papers,
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